Transient Ischemic Attack
📧 Sign up to get email alerts when something new happens for Transient Ischemic Attack.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-09-16FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approves a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, pertaining to the approved generic prod…
-
FDA approval · 2022-03-31FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (Radha Pharmaceuticals, Inc.) under an ANDA, confirming its status as a ge…
-
FDA approval · 2021-12-21FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited. The action confirms approva…
-
FDA approval · 2021-10-06FDA Approved: ASPIRIN AND DIPYRIDAMOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for aspirin and dipyridamole from Dr. Reddy's Laboratories Inc, confirming regulatory clearance …
-
FDA approval · 2021-08-11FDA Approved: ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (Micro Labs Limited)
FDA approved the original application for a generic aspirin and extended-release dipyridamole combination from Micro Labs Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-04-14FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE from Glenmark Pharmaceuticals Inc., USA, authorizing th…
-
FDA approval · 2019-12-13FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for Clopidogrel Bisulfate from Radha Pharmaceuticals, Inc., confirming approval of their generic pro…
-
FDA approval · 2019-08-02FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' supplemental application for clopidogrel bisulfate, approving changes to the product's labeling.
-
FDA approval · 2019-05-24FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original application for a generic aspirin and extended-release dipyridamole product.
-
FDA approval · 2019-04-03FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for clopidogrel bisulfate from Aurobindo Pharma Limited, confirming regulatory approval for this gen…
-
FDA approval · 2019-03-10FDA Approved: ASPIRIN AND DIPYRIDAMOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for aspirin and dipyridamole (Dr. Reddy's Laboratories) to update/expand the product labeling fo…
-
FDA approval · 2017-07-10FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Plavix (clopidogrel) by Sanofi-Aventis U.S. LLC, resulting in changes to the product labeling.
-
FDA approval · 2017-01-18FDA Approved: ASPIRIN AND EXTENDED - RELEASE DIPYRIDAMOLE CAPSULES, 25 MG / 200 MG — Original Application (Endo USA, Inc.)
FDA approves Endo USA's aspirin and extended-release dipyridamole capsules (25 mg/200 mg) for reducing the risk of stroke in patients who ha…
-
FDA approval · 2016-05-11FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
The FDA approved a supplemental application filed by Dr. Reddy's Laboratories Inc for clopidogrel bisulfate (generic) to support changes to …
-
FDA approval · 2016-05-11FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for CLOPIDOGREL BISULFATE submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2016-03-08FDA Approved: ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (AvKARE)
The FDA approved AvKARE's aspirin and extended-release dipyridamole as an original-application product (ANDA). It is indicated to reduce the…
-
FDA approval · 2015-07-28FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approved a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, for a generic version of clopidogrel.
-
FDA approval · 2015-07-16FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA lists a supplemental application for Plavix (clopidogrel) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2014-03-04FDA Approved: CLOPIDOGREL — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original generic application for clopidogrel bisulfate (clopidogrel).
-
FDA approval · 2013-12-12FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' clopidogrel bisulfate as an original application (ANDA), enabling a generic version of the antiplatel…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic clopidogrel; an antiplatelet agent used to reduce cardiovascular events in patients with acute coronary syndrome…
-
FDA approval · 2010-05-18FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for clopidogrel bisulfate, a generic version of clopidogrel. The ap…
-
FDA approval · 2007-10-22FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2007-05-11FDA Approved: PRAVASTATIN SODIUM — Original Application (CIPLA USA INC.)
FDA approved a generic pravastatin sodium product (Pravastatin Sodium) from Cipla USA Inc. through an Original Application (ANDA). This mark…